41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
3512564
319423
2
Public Timelines
FAQ

jan 1, 2014 - Pembrolizumab

Description:

Pembrolizumab is approved for advanced melanoma treatment by the FDA. This monoclonal antibody blocks a protein called PD1's activity on immune cells, which increases the strength of the immune response to cancer.

Added to timeline:

14 Nov 2019
0
0
309

Date:

jan 1, 2014
Now
~ 12 years ago